STRYKER CORP Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- STRYKER CORP stock issued during period, value, new issues for the quarter ending 2012-03-31 was $8.00M, a 11.11% decline year-over-year.
- STRYKER CORP stock issued during period, value, new issues for the quarter ending 2011-12-31 was $3.00M.
- STRYKER CORP stock issued during period, value, new issues for the quarter ending 2011-09-30 was $1.80M, a 45.45% decline year-over-year.
- STRYKER CORP stock issued during period, value, new issues for the quarter ending 2011-06-30 was -$800.00K, a 144.44% decline year-over-year.
- STRYKER CORP stock issued during period, value, new issues for fiscal 2011 was $13.00M, a 13.33% decline from fiscal 2010.
- STRYKER CORP stock issued during period, value, new issues for fiscal 2010 was $15.00M, a 40.00% decline from fiscal 2009.
- STRYKER CORP stock issued during period, value, new issues for fiscal 2009 was $25.00M, a 64.03% decline from fiscal 2008.
- STRYKER CORP stock issued during period, value, new issues for fiscal 2008 was $69.50M, a 13.88% decline from fiscal 2007.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2012-03-31 | $8.00M 10-Q · filed 2012-04-24 | $12.00M derived: sum of 4 quarters · filed 2012-04-24 |
| 2011-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | $13.00M 10-K · filed 2012-02-13 |
| 2011-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $8.10M derived: sum of 4 quarters · filed 2012-02-13 |
| 2011-06-30 | -$800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $9.60M derived: sum of 4 quarters · filed 2012-02-13 |
| 2011-03-31 | $9.00M 10-Q · filed 2011-05-04 | $12.20M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | $15.00M 10-K · filed 2012-02-13 |
| 2010-09-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | $17.90M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $16.10M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-03-31 | $11.80M 10-Q · filed 2010-04-29 | |
| 2009-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | $25.00M 10-K · filed 2012-02-13 |
| 2009-09-30 | $1.50M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-11-09 | |
| 2008-12-31 | $69.50M 10-K · filed 2011-02-18 | |
| 2007-12-31 | $80.70M 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |